Efficacy and Safety of the Combination of Anlotinib and JS001 in EGFR-TKI Resistant T790M-Negative NSCLC

Clinical trial NCT04116918 · UNKNOWN

Trial details

NCT number: NCT04116918
Sponsor: Baodong Qin
Status: UNKNOWN
Study type: OBSERVATIONAL

NSCLC Stage IV EGFR T790M-negative Anlotinib JS001

Start date: 2019-09-01
Primary completion: 2021-09-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.